Skybiotech Healthcare Limited Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | TBA | 0.02 | 0.03 |
| Operating Expense | 0.06 | 0.01 | 0.04 |
| Net Profit | -0.06 | 0.01 | -0.01 |
| Net Profit Margin | TBA | 50 | -33.33 |
| Earning Per Share | 0.30 | -0.41 | 0.27 |
| EBIDTA | -0.06 | 0.01 | -0.01 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Dec 2025 |
|---|---|
| Revenue | TBA |
| Operating Expense | 0.06 |
| Net Profit | -0.06 |
| Net Profit Margin | TBA |
| Earning Per Share | 0.30 |
| EBIDTA | -0.06 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.11 | 0.13 | 0.06 |
| Operating Profit Annual | 0.08 | 1.88 | -0.01 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 0.00 | 0.00 | 0.00 |
| Net Profit Annual | 0.06 | 1.54 | -0.01 |
| Tax Annual | 0.02 | 0.34 | -0.00 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.11 |
| Operating Profit Annual | 0.08 |
| Interest Annual | TBA |
| Depreciation | 0.00 |
| Net Profit Annual | 0.06 |
| Tax Annual | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 8.43 | 0.02 | 0.01 |
| Cash Flow from Operations | 0.30 | -1.34 | -0.37 |
| Cash Flow from Investing | -9.30 | 3.63 | 0.38 |
| Cash Flow from Financing | 0.55 | 6.13 | TBA |
| Cash Flow at the End | -0.02 | 8.43 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 8.43 |
| Cash Flow from Operations | 0.30 |
| Cash Flow from Investing | -9.30 |
| Cash Flow from Financing | 0.55 |
| Cash Flow at the End | -0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | -0.44 | 0.14 | -0.83 |
| Return On Networth /Employed (%) | -0.44 | 0.14 | -0.83 |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | -0.44 |
| Return On Networth /Employed (%) | -0.44 |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.00 | 0.00 | 0.01 |
| Total Current Assets Annual | 0.15 | 8.60 | 0.02 |
| Non Current Assets Annual | 12.48 | 2.93 | 4.04 |
| Total Shareholders Funds Annual | 11.78 | 10.83 | 3.49 |
| Total Assets Annual | 12.62 | 11.53 | 4.06 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.00 |
| Total Current Assets Annual | 0.15 |
| Non Current Assets Annual | 12.48 |
| Total Shareholders Funds Annual | 11.78 |
| Total Assets Annual | 12.62 |
EPS (INR)
Expected
0.00
Reported
-1.29
Surprise
0.00%
Sep 2025
EPS beaten by 0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
